Mercodia is a Swedish life science company and experienced bioanalytical CRO with over 30 years in the field, specializing in analytical solutions for large molecule therapeutics and biomarkers. We develop and manufacture high-quality immunoassays for research and clinical diagnostics, with a core focus on biomarkers for diabetes, obesity, and cardiometabolic diseases. From our GLP-compliant laboratories in Europe and the US, we provide cost-effective bioanalytical services spanning preclinical to clinical phases of drug development programs. We support pharmaceutical, biotech, and academic teams by ensuring regulatory compliance while optimizing cost and efficiency. Renowned for our reliability, scientific expertise, and commitment to quality, Mercodia is your trusted partner, helping scientists worldwide generate high-quality data for confident decision-making.
| Website | http://www.mercodia.com |
| Revenue | $17.2 million |
| Employees | 80 (65 on RocketReach) |
| Founded | 1991 |
| Phone | (461) 857-0070 |
| Industry | Biotechnology Research, Manufacturing, Development and manufacturing of ELISA assays for clinical and r, Obesity And Cardiovascular Disease |
| Web Rank | 5 Million |
| Keywords | Bioanalysis, Assay Development, Assay Validation, Biomarker Analysis, Immunoassay Kits, Diagnostic Assays, Pharma Services, Biotech Services, In Vitro Diagnostics, Biomarker Discovery, Drug Development, Clinical Diagnostics, Therapeutic Drug Monitoring, Precision Medicine, Life Science Research, Pharmaceutical Research |
| Competitors | Roche, Thermo Fisher Scientific, Siemens, Medtronic, Abbott, Eurofins, abcam, KPL, Beckman Coulter Diagnostics +41 more (view full list) |
Looking for a particular Mercodia employee's phone or email?
The Mercodia annual revenue was $17.2 million in 2026.
Jörgen Dahlström is the CEO of Mercodia.
65 people are employed at Mercodia.